Details of the Drug Reposition

General Information of This Drug (ID: DMF936G)

Drug Name
CD19CART   DMF936G
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Clinical trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
leukaemia DISS7D1V 2A60-2B33 Clinical trial [1]
B-cell lymphoma DISIH1YQ 2A86 Clinical trial [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02813837) Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies